Innovative drugs mark the ‘before’ and ‘after’ of the approach to fighting cancer

The importance of biomedical innovation for European development and competitiveness

Farmmaindustria CEO Juan Yermo, European Commission health director Sandra Gallina and other EU political and business representatives analyze the role of incentives for research into new drugs. + read more

Problems of gradual introduction of innovations in medicines and their use in Spain

In Spain, a study estimates that a 10% increase in adherence rates for 4 high-incidence diseases would mean savings of more than €500 million in direct health care costs due to incremental drug innovations. + read more

The OptimIA project won the IV SEFH Innovation Forum

OptimIA, through the analysis of various variables and methods machine learning, will provide more evidence on the best use of drugs, predict response patterns and toxicity to anticipate reactions. + read more

Evinova, a new digital health business to accelerate innovation in life sciences

Evinova will operate as an independent medical technology unit within AstraZeneca. + read more

Innovations in medical care through PROMS at the Class III Center for Economics and Health Outcomes

This course edition, titled “Innovation through PROMS: Real-World Data,” aims to stimulate research by integrating real-world data to identify patterns, personalize treatments, and improve patient care. + read more

Surgical innovations improve treatment of liver cancer

Hepatocellular carcinoma is the most common liver cancer, with 60% to 90% of cases associated with cirrhosis. + read more